uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Enhanced sensitivity to IGF-II signalling links loss of imprinting of IGF2 to increased cell proliferation and tumour risk
Show others and affiliations
2007 (English)In: Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, Vol. 104, no 52, 20926-20931 p.Article in journal (Refereed) Published
Abstract [en]

Loss of imprinting (LOI) of the insulin-like growth factor-II gene (IGF2), leading to abnormal activation of the normally silent maternal allele, is a common human epigenetic population variant associated with a 5-fold increased frequency of colorectal neoplasia. Here, we show first that LOI leads specifically to increased expression of proliferation-related genes in mouse intestinal crypts. Surprisingly, LOI(+) mice also have enhanced sensitivity to IGF-II signaling, not simply increased IGF-II levels, because in vivo blockade with NVP-AEW541, a specific inhibitor of the IGF-II signaling receptor, showed reduction of proliferation-related gene expression to levels half that seen in LOI(-) mice. Signal transduction assays in microfluidic chips confirmed this enhanced sensitivity with marked augmentation of Akt/PKB signaling in LOI(+) cells at low doses of IGF-II, which was reduced in the presence of the inhibitor to levels below those found in LOI(-) cells, and was associated with increased expression of the IGF1 and insulin receptor genes. We exploited this increased IGF-II sensitivity to develop an in vivo chemopreventive strategy using the azoxymethane (AOM) mutagenesis model. LOI(+) mice treated with AOM showed a 60% increase in premalignant aberrant crypt foci (ACF) formation over LOI(-) mice. In vivo IGF-II blockade with NVP-AEW541 abrogated this effect, reducing ACF to a level 30% lower even than found in exposed LOI(-) mice. Thus, LOI increases cancer risk in a counterintuitive way, by increasing the sensitivity of the IGF-II signaling pathway itself, providing a previously undescribed epigenetic chemoprevention strategy in which cells with LOI are "IGF-II addicted" and undergo reduced tumorigenesis in the colon upon IGF-II pathway blockade.

Place, publisher, year, edition, pages
2007. Vol. 104, no 52, 20926-20931 p.
Keyword [en]
Akt, cancer, chemoprevention, epigenetics, signal transduction
National Category
Biological Sciences
URN: urn:nbn:se:uu:diva-113042DOI: 10.1073/pnas.0710359105ISI: 000252077400056OAI: oai:DiVA.org:uu-113042DiVA: diva2:289735
Available from: 2010-01-25 Created: 2010-01-25 Last updated: 2010-02-10Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full texthttp://www.pnas.org/content/104/52/20926.abstract
By organisation
Department of Physiology and Developmental Biology
In the same journal
Proceedings of the National Academy of Sciences of the United States of America
Biological Sciences

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 206 hits
ReferencesLink to record
Permanent link

Direct link